The Effect of Pharmaceutical Grade L-glutamine (Endari) on Glycemic Control in Patients With Diabetes Mellitus Type II
Latest Information Update: 04 May 2022
At a glance
- Drugs Glutamine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
Most Recent Events
- 27 Jun 2019 According to an Emmaus Life Sciences media release, Frank Singer, M.D., of Straub Medical Center in Honolulu, Hawaii, is the co-investigator of the trial.
- 24 Jun 2019 According to an Emmaus Life Sciences media release, first patient has been dosed in the study.
- 24 Jun 2019 Status changed from not yet recruiting to recruiting, according to an Emmaus Life Sciences media release.